acy-1215
Showing 1 - 6 of 6
Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)
Active, not recruiting
- Recurrent Chronic Lymphoid Leukemia
- ACY-1215
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)
Completed
- Multiple Myeloma
- ACY-1215
- +2 more
-
Boston, Massachusetts
- +4 more
Feb 7, 2022
Metastatic Breast Cancer, Breast Carcinoma Trial in New York (ACY-1215, Nab-paclitaxel)
Completed
- Metastatic Breast Cancer
- Breast Carcinoma
- ACY-1215
- Nab-paclitaxel
-
New York, New YorkColumbia Irving University Medical Center
Jan 5, 2021
Lymphoma, Lymphoid Malignancies Trial in Tampa, New York (ACY-1215)
Completed
- Lymphoma
- Lymphoid Malignancies
- ACY-1215
-
Tampa, Florida
- +1 more
Feb 6, 2020
Multiple Myeloma Trial in United States (ACY-1215)
Completed
- Multiple Myeloma
- ACY-1215
-
Atlanta, Georgia
- +5 more
Apr 5, 2017
Healthy Trial in Madison (ACY-1215)
Completed
- Healthy
- ACY-1215
-
Madison, WisconsinCovance Clinical Research Unit Incorporated
Sep 10, 2014